• head_banner_01

ပရိုတိန်းကို synthesin အတွက်အသုံးပြုအမိုင်နိုအက်ဆစ်၏အညစ်အကြေး

အသေးစိတ်ဖော်ပြချက်:

NO

ထုတ်ကုန်များ

CAs No

1

fmoc-d-Ala-D-Ala-oh

NA

2

fmoc-β-Ala-D-Ala-oh

NA

3

FMOC-arg (PBF) -argarg (PBF) -oh

NA


ထုတ်ကုန်အသေးစိတ်

ထုတ်ကုန်အမှတ်အသားများ

ထုတ်ကုန်အသေးစိတ်

NO

ထုတ်ကုန်များ

CAs No

အဓိကအရည်အသွေးအညွှန်းကိန်း

သန့်ရှင်းြရဲ

မက်စ်။

ညစ်ညူးခြင်း

စုစုပေါင်းအရည်ပျော်ပစ္စည်းအကြွင်းအကျန်

စိုထိုင်းဆ

1

fmoc-β-Ala-Ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

fmoc-d-Ala-D-Ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

fmoc-β-Ala-D-Ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMOC-arg (PBF) -argarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-Ala-arg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

fmoc-d-arg (PBF) -D-arg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-Ala-D-arg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-Homoarg (PBF) -homoarg (PBF) -homoargharge

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-Ala-Ala-Homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

fmoc-asn (trt) -asn (trt) -aoh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

fmoc-β-Ala-Asn (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

FMOC-ASP (OTBU) -asp (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-Ala-Asp (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

fmoc-cys (trt) -cys (trt) -cys

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

fmoc-β-Ala-cys (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

fmoc-cys (ACM) -Cy (ACM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

fmoc-β-Ala-cys (ACM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

FMOC-GLN (TRIT) -GLN (TRT) -loh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-Ala-GLN (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

FMOC-Glu (OTBU) -Glu (OTBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

fmoc-β -la-glu (otbu) -oh.h2o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

FMOC-β-Ala-gly-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

fmoc-န်းမာ (TRT) -His (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-Ala-all (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

fmoc-file-iile-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-Ala-fil-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

fmoc-leu-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

fmoc-β-ala-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

fmoc-d-leu-d-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

fmoc-β-ala-d-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-LYS (BOC) -lys (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

fmoc-β-ala-lys (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-LYS (Alloc) -lys (Alloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

fmoc-β-ala-lys (alloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

fmoc-met-met-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

fmoc-β -la-met-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

FMOC-Orn (BOC) -orn (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

fmoc-β-ala-orn (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

fmoc-phe-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

fmoc-β-ala-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

fmoc-d-phe-d-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

fmoc-β-ala-d-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

FMOC-Pro-Pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

fmoc-β-Ala-Pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-SER (TBU) -ser (TBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-Ala-SER (TBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-SER (TRT) -ser (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

fmoc-β -la-ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

FMOC-THR (TBU) -

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

fmoc-β-ala-ther (Tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -trp (BOC) -troh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

fmoc-β-Ala-trp (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-trp (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-Ala-D-TRP (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

FMOC-Tyr (Tbu) -tyr (TBU) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-Ala-Tyr (Tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

fmoc-d-tyr (et) -D-Tyr (ET) -eoh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

fmoc-β-ala-d-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

fmoc-tyr (ငါ့ကို) -tyr (ငါ့ကို) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

FMOC-β-Ala-Tyr (Meoh) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

fmoc-val-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

fmoc-β-ala-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

fmoc-d-cit-cit-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

fmoc-β-Ala-D-Cit-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

fmoc-β-ala-dab-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

fmoc- (3- (2-naphthyl) -D-Ala) 2-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-Ala-3- (2-naphthyl) -D-Ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

fmoc- (3- (3 pyridyll) -D-Ala) 2-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-Ala-3- (3 pyridyll) -D-Ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

fmoc- (4-chloro-d-phe) 2-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

fmoc-β-ala-4-4-chloro-d-D-Phe- အိုး

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

fmoc- (D-4 (tbucbm)) 2-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

fmoc-β-ala-d-4 (tbucbm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

fmoc-aph (l-hor) - သပ် (L-hor) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

fmoc-β-ala-aph (l-hor) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMOC-LYS (IPR, BOC) -lys (IPR, BOC) -Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

fmoc-β-ala-lys (IPR, BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

fmoc-β-Ala-Aeea-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

fmoc-aib-aib-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

fmoc-β-ala-aib-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

fmoc-arg-oh

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-arg (PBF) -oh

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

fmoc-d-arg-oh

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-arg (PBF) -oh

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

fmoc-homoarg-oh.hcl

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

fmoc-d-homoarg-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-homoarg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

fmoc-asn-oh

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-Asn (TRT) -oh

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

fmoc-asp-oh

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-Asp (OTBU) -oh

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

fmoc-cys-oh

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-gys (trt) -oh

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-cys (ACM) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

fmoc-gln-oh

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-GLN (TRT) -oh

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

fmoc-glu-oh

121333-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-Glu (OTBU) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

fmoc-he he

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-TRY (TRT) -oh

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

BOC-hem

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

fmoc-lys-oh

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-Lys (BOC) -oh

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-Lys (Alloc) -oh

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

FMOC-ORN-OH.HCL

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-Orn (BOC) -oh

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

fmoc-ser-oh

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-SER (TBU) -oh

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-SER (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

fmoc-thr.h2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-THR (TBU) -oh

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

fmoc-trp-oh

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-TRP (BOC) -oh

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

fmoc-d-trp-oh

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -oh

201290-11-1-11

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

fmoc-tyr-oh

92954-90-0-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-Tyr (Tbu) -oh

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

fmoc-d-tyr-oh

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-Tyr (ET) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-Tyr (Me) -oh.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4 (CBM) -oh

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4 (TBUCBM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

FMOC-LYS (IPR) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-Lys (IPR, BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

အကေြာင်း

လေျာ်ခြင်း

Gentleex သည်အရည်အသွေးကောင်းသည့်ထုတ်ကုန်များကိုပေးသည်, အကယ်. ကုန်ပစ္စည်းအရည်အသွေးကို 0 န်ဆောင်မှုခံယူသူမှ 0 န်ဆောင်မှုခံယူသူမှ 0 န်ဆောင်မှုခံယူသူအားလုံလောက်သောအထောက်အထားများဖြင့် 0 န်ဆောင်မှုခံယူရန်လိုအပ်ပါကကျွန်ုပ်တို့သည်လိုအပ်သောအကဲဖြတ်ခြင်းနှင့်အကဲဖြတ်ခြင်းများကိုပေးလိမ့်မည်။

ထုတ်ဖေါ်ခြင်း

ဆေးဝါးထုတ်ကုန်များရရှိသည့်ဆေးဝါးများသည်တန်ချိန်စံချိန်တင်ရရှိသည်, ဓာတုပစ္စည်းများ၏စွမ်းဆောင်ရည်သည် 100tons + တန်းသို့ရောက်ရှိသည်။

သုတေသနနှင့်ဖွံ့ဖြိုးတိုးတက်မှု

နှစ်စဉ် R & D အဖွဲ့မှတပ်ဆင်ထားသည့်ထုတ်ကုန်အသစ်များတည်ဆောက်ရန်အစီအစဉ်များကိုတည်ဆောက်ရန်အစီအစဉ်ရှိသည်, ရည်မှန်းချက်များချမှတ်သောအခါအဖွဲ့ 0 င်တိုင်းသည် KPI တာဝန်ယူမှုနှင့်မက်လုံးပေးမူဝါဒများနှင့်ဆက်လက်လုပ်ဆောင်ရန်လိုအပ်လိမ့်မည်။


  • ယခင်:
  • နောက်တစ်ခု:

  • ဤနေရာတွင်သင်၏စာကိုရေးပြီးကျွန်ုပ်တို့ထံပို့ပါ